Milnacipran (Savella) and Ketamine Therapy | Tovani Health
Savella (Milnacipran) — SNRI (FDA-approved for fibromyalgia)
Verdict at Tovani Health
Compatible; same SNRI considerations as Cymbalta and Effexor.
Milnacipran and ketamine are compatible. FDA-approved specifically for fibromyalgia (not depression in the US, though used as an antidepressant elsewhere). Same SNRI compatibility framework as duloxetine and venlafaxine: track BP (SNRIs raise baseline BP that stacks with ketamine's transient pressor), and don't discontinue abruptly (SNRI discontinuation syndrome is real).
If you take Savella regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or modest dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How Savella interacts with ketamine
Milnacipran inhibits serotonin and norepinephrine reuptake with greater NE-than-serotonin selectivity than other SNRIs. Renally cleared with minimal CYP metabolism.
What we do at intake
Disclose dose. Baseline BP. Tell us about any recent dose changes.
Bottom line
Milnacipran and ketamine are compatible. FDA-approved specifically for fibromyalgia (not depression in the US, though used as an antidepressant elsewhere). Same SNRI compatibility framework as duloxetine and venlafaxine: track BP (SNRIs raise baseline BP that stacks with ketamine's transient pressor), and don't discontinue abruptly (SNRI discontinuation syndrome is real).
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Savella (Milnacipran) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants. Montgomery SA. CNS Spectrums. 2008. PMID: 18622372
- Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions. Riva-Posse P, Reiff CM, Edwards JA. Journal of Affective Disorders. 2018. PMID: 29525051
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.